2-pyrrolino-dox has been researched along with isoflurophate in 1 studies
| Studies (2-pyrrolino-dox) | Trials (2-pyrrolino-dox) | Recent Studies (post-2010) (2-pyrrolino-dox) | Studies (isoflurophate) | Trials (isoflurophate) | Recent Studies (post-2010) (isoflurophate) |
|---|---|---|---|---|---|
| 28 | 0 | 2 | 3,337 | 1 | 123 |
| Protein | Taxonomy | 2-pyrrolino-dox (IC50) | isoflurophate (IC50) |
|---|---|---|---|
| Acetylcholinesterase | Electrophorus electricus (electric eel) | 0.48 | |
| Lysosomal protective protein | Homo sapiens (human) | 10 | |
| Fatty acid synthase | Rattus norvegicus (Norway rat) | 0.05 | |
| Acetylcholinesterase | Homo sapiens (human) | 0.12 | |
| Liver carboxylesterase | Sus scrofa (pig) | 0.05 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nagy, A; Plonowski, A; Schally, AV | 1 |
1 other study(ies) available for 2-pyrrolino-dox and isoflurophate
| Article | Year |
|---|---|
Stability of cytotoxic luteinizing hormone-releasing hormone conjugate (AN-152) containing doxorubicin 14-O-hemiglutarate in mouse and human serum in vitro: implications for the design of preclinical studies.
Topics: Adult; Animals; Antineoplastic Agents; Bombesin; Carboxylesterase; Carboxylic Ester Hydrolases; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Doxorubicin; Drug Evaluation, Preclinical; Drug Interactions; Drug Stability; Gonadotropin-Releasing Hormone; Half-Life; Humans; Hydrolysis; Isoflurophate; Male; Mice; Mice, Nude; Nitrophenols; Paraoxon; Pyrroles; Weight Loss | 2000 |